TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Simcere Pharmaceutical Group Limited ( (HK:2096) ) has shared an announcement.
Simcere Pharmaceutical Group Limited announced a supplemental update regarding its connected transaction involving the acquisition of assets from Sanroad Shanghai and the entire equity interest in Xianwei. This strategic move is expected to enhance Simcere’s operational capabilities and market positioning by expanding its asset base and potentially increasing its influence in the pharmaceutical sector.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. The company focuses on the development, production, and distribution of pharmaceutical products, with a market presence that spans various therapeutic areas.
Average Trading Volume: 23,125,103
Technical Sentiment Signal: Buy
Current Market Cap: HK$33.95B
Find detailed analytics on 2096 stock on TipRanks’ Stock Analysis page.